Pelitinib
| Pelitinib | |
|---|---|
| Term | Pelitinib |
| Short definition | Pelitinib - (pronounced) (peh-LIH-tih-tip) substance being studied to treat some types of cancer. It blocks the action of certain proteins that are part of the epidermal growth factor receptor (EGFR) family of proteins. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
Pelitinib - (pronounced) (peh-LIH-tih-tip) substance being studied to treat some types of cancer. It blocks the action of certain proteins that are part of the epidermal growth factor receptor (EGFR) family of proteins. These proteins can be found in elevated amounts on the surface of some types of cancer cells. Blocking the action of these proteins can stop cancer cells from growing and kill cancer cells. Pelitinib is a type of EGFR inhibitor. Also called EKB-569
External links
- Medical encyclopedia article on Pelitinib
- Wikipedia's article - Pelitinib
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski